Fine deletion mapping of chromosome 8p in non-small-cell lung carcinoma
Open Access
- 11 June 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 81 (6) , 854-858
- https://doi.org/10.1002/(sici)1097-0215(19990611)81:6<854::aid-ijc3>3.0.co;2-1
Abstract
Several somatic genetic alterations have been described in non‐small‐cell lung carcinomas (NSCLC). Recurrent chromosomal deletions have suggested the presence of tumor‐suppressor genes specifically involved in lung carcinogenesis. For one of these, 2 non‐overlapping regions have been proposed on the short arm of chromosome 8, encompassing the LPL and NEFL genes. The LPL region has been extensively studied in NSCLC and other cancer types. Two genes, N33 and PRLTS, have been identified, but the small number of mutations excludes their involvement in the vast majority of tumors. In order to delineate a reliable region of deletional overlap on chromosome 8p in NSCLC, a series of 77 NSCLC was studied for 34 microsatellite polymorphisms distributed on chromosome 8p, using multiplex‐PCR amplification. After purification of tumor nuclei by flow cytometry based on either the abnormal DNA index or the presence of a high expression of cytokeratin, allelic losses on chromosome 8p were observed in 39% of cases. Measurement of DNA index showed that 62% of tumors were hyperploid; allelic losses were more frequent in hyperploid than in diploid tumors (54% vs. 14%; p < 10−4). Deletions of part of the short arm were observed in 7 instances. Our data allow definition of an interval of common deletion, flanked by the loci D8S511 and D8S1992, where the putative tumor‐suppressor gene might be localized. Int. J. Cancer 81:854–858, 1999.Keywords
This publication has 16 references indexed in Scilit:
- Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lungBritish Journal of Cancer, 1998
- Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancerBritish Journal of Cancer, 1996
- Enrichment of tumor cells for cell kinetic analysis in human tumor biopsies using cytokeratin gatingRadiotherapy and Oncology, 1996
- LOSS OF HETEROZYGOSITY AT 5q21 IN NON-SMALL CELL LUNG CANCER: A FREQUENT EVENT BUT WITHOUT EVIDENCE OFAPC MUTATIONThe Journal of Pathology, 1996
- Physical Mapping of Chromosome 8p22 Markers and Their Homozygous Deletion in a Metastatic Prostate CancerGenomics, 1996
- Prognostic significance of p53 andras p21 expression in nonsmall cell lung cancerCancer, 1995
- Bivariate cytokeratin/DNA flow cytometric analysis of paraffin-embedded samples from colorectal carcinomasCytometry, 1995
- Allele-Specific Loss in Chromosome 9p Loci in Preneoplastic Lesions Accompanying Non-Small-Cell Lung CancersJNCI Journal of the National Cancer Institute, 1995
- Correlation of loss of heterozygosity at 11 p with tumour progression and survival in non-small cell lung cancerGenes, Chromosomes and Cancer, 1994
- A 3‐Mb physical map of the chromosome region 8p21.3‐p22, including a 600‐kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non‐small cell lung cancerGenes, Chromosomes and Cancer, 1994